Mankind Pharma Combats Leprosy with Lepra Society

Mankind Pharma combats leprosy, partners with Lepra Society to screen 80,000 individuals

Mankind Pharma, a leading pharmaceutical company in India, has announced a strategic partnership with the Lepra Society to launch a comprehensive initiative aimed at eradicating, raising awareness, and treating leprosy. Under their CSR arm, the company is committed to making a meaningful impact in regions affected by leprosy, and as part of this commitment, they have established five exclusive Comprehensive Disability Care Centres (CDCC) across different locations.

CDDS: Strategic Locations 

• The CDCCs are strategically positioned in regions identified as high-impact areas, including the NTR District in Andhra Pradesh, Guru Gobind Hospital in Delhi, the Government Hospital in Chandarpur, Maharashtra, the Community Care Centre in Odisha, Koraput, and Nirmal District in Telangana. 

• These centres are operational throughout the year, addressing various issues related to leprosy and elephantiasis. 

• The company aims to provide essential treatment and raise awareness through these centres, collaborating closely with the Lepra Society.

Words from CEO

Sheetal Arora, CEO,  Mankind Pharma, said, “Our partnership with the Lepra Society is a step forward in our mission to eradicate leprosy and create awareness. The CDCCs in key regions will play a crucial role in providing treatment and support to those affected by leprosy. We hope that the targeted communities will benefit from this renewed focus on leprosy. 

Social-Welfare Work

Mankind Pharma will undertake a range of vital activities to combat leprosy and its socio-economic impacts. Over 80,000 individuals will undergo comprehensive screening, accompanied by extensive awareness programme designed to educate and inform communities.
 
Additionally, the initiative aims to provide treatment to more than 6,000 patients through the morbidity management and disability programme, showcasing the commitment to holistic care. Over 10 reconstructive surgeries are slated to take place, aimed at restoring normalcy for affected individuals. It will also extend socio-economic support to over 400 families, addressing the multi-faceted challenges faced by communities.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!